Fact 1
The first description of GM1 gangliosidosis was in 1959. Svennerholm’s standardized ganglioside nomenclature, published in 1963, showed that the ganglioside accumulating in these patients was structurally different from the one in Tay-Sachs disease, and in 1965 O’Brien and colleagues proposed generalized gangliosidosis as another inborn error of ganglioside metabolism. In 1968, the lysosomal enzyme beta-galactosidase was discovered to be the underlying cause of the ganglioside accumulation.
Fact 2
Some genes, like GLB1, are associated with more than one disease. The GLB1 gene is associated with both GM1 gangliosidosis and MPS IVB.
Fact 3
The publicly searchable version of the Human Gene Mutation Database currently catalogues 265 known pathogenic, or disease-causing, mutations in the GLB1 gene, the gene behind both GM1 gangliosidosis and Morquio B. Counts differ between databases: as of August 2026, ClinVar classifies 354 GLB1 variants as pathogenic or likely pathogenic.
Fact 4
GM1 gangliosidosis is one of more than 70 lysosomal diseases currently known.
Fact 5
An autosomal recessive inheritance pattern is one of several ways a trait, disorder, or disease can be passed down through families. An autosomal recessive disorder means two copies of an abnormal gene must be present in order for the disease or trait to develop. This means a child has to inherit the gene mutation from both carrier parents.
Fact 6
Our brains are the control centers for our bodies. This organ is so vital that to protect it, a barrier called the blood brain barrier controls what enters it. While the blood brain barrier protects the brain from toxins, it also makes it really hard to deliver useful therapies and medications to the brain.
Fact 7
GM1 gangliosidosis is a lysosomal storage disorder. Lysosomal storage disorders are disorders where insufficient quantities of certain enzymes needed to break down molecules exist, or the enzymes are absent all together. As a result, the molecules can accumulate to toxic levels in the body.
Fact 8
Lysosomes are compartments within cells that act as the waste disposal system of the cell. They contain enzymes that break down large molecules such as proteins, carbohydrates, and lipids. They then pass the digested fragments on to other parts of the cell for recycling.
Fact 9
The enzyme beta-galactosidase helps break down molecules in lysosomes, including a substance called GM1 ganglioside.
Fact 10
Gangliosides are among the most abundant molecules in the nervous system, and they matter both to the developing brain and to the mature one. When the enzymes that build gangliosides fail, the result is severe neurodegenerative disease that often begins in infancy or childhood, and the balance of gangliosides in the brain shifts in normal aging as well. In the gangliosidosis diseases the problem runs the other way: ganglioside that cannot be cleared builds up until it damages cells and tissues throughout the body.
Fact 11
Cherry red spots can appear in the macula of the eye in a variety of lipid storage diseases. This can include babies impacted by Type 1 or infantile GM1 gangliosidosis.
Fact 12
GM1 gangliosidosis affects one in every 100,000 to 200,000 live births within the general population. Though in some areas of the world, like Malta, southern Brazil, Cyprus, and among people of Roma ancestry, there is a higher incidence of GM1.
Rha et al., 2021 ยท Lenicker et al., 1997 ยท Severini et al., 1999 ยท Georgiou et al., 2024 ยท Sinigerska et al., 2006
Fact 13
GM1 gangliosidosis does not only occur in humans. Cats, dogs, and American black bears are all known to also inherit GM1.
References
Norman RM, Urich H, Tingey AH, Goodbody RA. Tay-Sachs’ disease with visceral involvement and its relationship to Niemann-Pick’s disease. J Pathol Bacteriol. 1959;78(2):409-421. doi:10.1002/path.1700780208. PMID 14427628.
Svennerholm L. Chromatographic separation of human brain gangliosides. J Neurochem. 1963;10(9):613-623. doi:10.1111/j.1471-4159.1963.tb08933.x. PMID 14066623.
O’Brien JS, Stern MB, Landing BH, O’Brien JK, Donnell GN. Generalized gangliosidosis: another inborn error of ganglioside metabolism? Am J Dis Child. 1965;109:338-346. doi:10.1001/archpedi.1965.02090020340014. PMID 14261015.
Okada S, O’Brien JS. Generalized gangliosidosis: beta-galactosidase deficiency. Science. 1968;160(3831):1002-1004. doi:10.1126/science.160.3831.1002. PMID 5647842.
Lysosomal Disease Network. Official list of lysosomal diseases. Provided via WORLDSymposium. https://worldsymposia.org/official-list-of-lysosomal-diseases/ Accessed August 15, 2026.
Platt FM, d’Azzo A, Davidson BL, Neufeld EF, Tifft CJ. Lysosomal storage diseases. Nat Rev Dis Primers. 2018;4(1):27. doi:10.1038/s41572-018-0025-4. PMID 30275469.
Human Gene Mutation Database (HGMD Public). GLB1 gene. Cardiff: Institute of Medical Genetics, Cardiff University. https://www.hgmd.cf.ac.uk/ac/gene.php?gene=GLB1 Accessed August 15, 2026.
ClinVar. GLB1 pathogenic and likely pathogenic variants. Bethesda (MD): National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/clinvar/?term=GLB1%5Bgene%5D+AND+%28%22clinsig+pathogenic%22%5BProperties%5D+OR+%22clinsig+likely+pathogenic%22%5BProperties%5D%29 Accessed August 15, 2026.
MedlinePlus Medical Encyclopedia. Autosomal recessive. Bethesda (MD): National Library of Medicine. https://medlineplus.gov/ency/article/002052.htm Accessed August 15, 2026.
Genetic and Rare Diseases Information Center (GARD). GM1 gangliosidosis. Bethesda (MD): National Center for Advancing Translational Sciences, NIH. https://rarediseases.info.nih.gov/diseases/10891/gm1-gangliosidosis Accessed August 15, 2026.
Pardridge WM. Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab. 2012;32(11):1959-1972. doi:10.1038/jcbfm.2012.126. PMID 22929442.
Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA. 1999;281(3):249-254. doi:10.1001/jama.281.3.249. PMID 9918480.
National Organization for Rare Disorders. Lysosomal storage disorders. https://rarediseases.org/rare-diseases/lysosomal-storage-disorders/ Accessed August 15, 2026.
National Human Genome Research Institute. Lysosome. Talking Glossary of Genomic and Genetic Terms. Bethesda (MD): National Institutes of Health. https://www.genome.gov/genetics-glossary/Lysosome Accessed August 15, 2026.
MedlinePlus Genetics. GLB1 gene. Bethesda (MD): National Library of Medicine. https://medlineplus.gov/genetics/gene/glb1/ Accessed August 15, 2026.
Sipione S, Monyror J, Galleguillos D, Steinberg N, Kadam V. Gangliosides in the brain: physiology, pathophysiology and therapeutic applications. Front Neurosci. 2020;14:572965. doi:10.3389/fnins.2020.572965. PMID 33117120.
Tripathy K, Patel BC. Cherry red spot. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Bookshelf ID NBK539841. https://www.ncbi.nlm.nih.gov/books/NBK539841/ Accessed August 15, 2026.
Rha AK, Maguire AS, Martin DR. GM1 gangliosidosis: mechanisms and management. Appl Clin Genet. 2021;14:209-233. doi:10.2147/TACG.S206076. PMID 33859490. Free full text at PMC8044076.
Lenicker HM, Vassallo Agius P, Young EP, Attard Montalto SP. Infantile generalized GM1 gangliosidosis: high incidence in the Maltese Islands. J Inherit Metab Dis. 1997;20(5):723-724. doi:10.1023/a:1005303332529. PMID 9323577.
Sinigerska I, Chandler D, Vaghjiani V, et al. Founder mutation causing infantile GM1-gangliosidosis in the Gypsy population. Mol Genet Metab. 2006;88(1):93-95. doi:10.1016/j.ymgme.2005.12.009. PMID 16466959.
Severini MH, Silva CD, Sopelsa A, Coelho JC, Giugliani R. High frequency of type 1 GM1 gangliosidosis in southern Brazil. Clin Genet. 1999;56(2):168-169. doi:10.1034/j.1399-0004.1999.560215.x. PMID 10517258.
Georgiou T, Petrou PP, Malekkou A, et al. Inherited metabolic disorders in Cyprus. Mol Genet Metab Rep. 2024;39:101083. doi:10.1016/j.ymgmr.2024.101083. PMID 38694234.
Universities Federation for Animal Welfare. GM1 gangliosidosis in the Korat cat. https://www.ufaw.org.uk/cats/korat—gm1-gangliosidosis–1 Accessed August 15, 2026.
Alroy J, Orgad U, DeGasperi R, et al. Canine GM1-gangliosidosis: a clinical, morphologic, histochemical, and biochemical comparison of two different models. Am J Pathol. 1992;140(3):675-689. PMID 1546746. Free full text at PMC1886155.
Muthupalani S, Torres PA, Wang BC, et al. GM1-gangliosidosis in American black bears: clinical, pathological, biochemical and molecular genetic characterization. Mol Genet Metab. 2014;111(4):513-521. doi:10.1016/j.ymgme.2014.02.002. PMID 24581871.